循环中的细胞因子水平与喘风险之间的因果关系:双向的门德尔随机化研究
Shan Lin1, Yuling Luo2, Qingyuan Zhan3
1Department of Respiratory and Critical Care Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Medicine
|July 23, 2025
概括
门德尔随机化确定了特定细胞因子和喘风险之间的因果关系. 较低的RANTES,MCP-1和GRO-α水平与喘易感性降低有关,而较高的β-NGF,TNF-α和M-CSF水平增加了喘风险.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 流行病学 流行病学
背景情况:
- 观察性研究表明,循环细胞因子和喘之间存在联系,但因果关系尚不清楚.
- 遗传因素在喘发育和细胞因子调节中起作用.
研究的目的:
- 通过使用孟德尔的随机化方法,研究循环中的细胞因子水平和喘易感性之间的潜在因果关系.
- 为了确定可能因果关系地影响喘风险的特定细胞因子.
主要方法:
- 采用欧洲参与者的公开可用的全基因组关联研究总结统计数据进行了双样本的门德尔随机化 (MR) 分析.
- 与循环中的细胞因子水平相关的遗传变异被用作仪器变量.
- 多种MR方法 (IVW,加权中位数,MR-Egger等) 和灵敏度分析 (MR-PRESSO) 用来确保可靠的因果推断和评估性.
主要成果:
- 基因预测较低的RANTES (CCL5),MCP-1和GRO-α水平与降低喘易感性 (ORs <1,P <0.05) 有因果关联.
- 基因预测的β神经生长因子 (β-NGF),瘤亡因子-α (TNF-α) 和巨菌群刺激因子 (M-CSF) 的较高水平与喘风险增加有关 (ORs > 1,P < 0.05).
- 灵敏度分析证实了这些发现的可靠性,并排除了显著的水平质变异.
结论:
- 这项研究提供了基因组证据,证明了特定循环细胞因子和喘易感性之间的因果关系.
- 兰特斯,MCP-1,GRO-α,β-NGF,TNF-α和M-CSF被确定为喘发病的潜在因果因素.
- 这些发现突出了这些细胞因子在喘发展中的免疫病原作用,并表明了潜在的治疗点.
更多相关视频
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.2K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
544
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
01:20Asthma: Pathogenesis and Management
599
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
599
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:20The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
469
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
469
01:19Antiasthma Drugs: Leukotriene Modifiers
483
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
483